IV/arterial administration air bubble detectors

STING agonist-7 is a non-nucleotide STING agonist. STING agonist-7 binds selectively to mouse STING but not human STING . STING agonist-7 penetrates cell membrane poorly.Appearance:SolidIn Vitro:STING agonist-7 (compound 11) is active in biochemical

STING agonist-7 is a non-nucleotide STING agonist. STING agonist-7 binds selectively to mouse STING but not human STING . STING agonist-7 penetrates cell membrane poorly.Appearance:SolidIn Vitro:STING agonist-7 (compound 11) is active in biochemical

STING agonist-7 is a non-nucleotide STING agonist. STING agonist-7 binds selectively to mouse STING but not human STING . STING agonist-7 penetrates cell membrane poorly.Appearance:SolidIn Vitro:STING agonist-7 (compound 11) is active in biochemical

STING agonist-7 is a non-nucleotide STING agonist. STING agonist-7 binds selectively to mouse STING but not human STING . STING agonist-7 penetrates cell membrane poorly.Appearance:SolidIn Vitro:STING agonist-7 (compound 11) is active in biochemical

STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selective and non-nucleotide small-molecule STING agonist with a pEC 50 and pIC 50 of 7.5 and 9.5, respectively. STING agonist-3 has durable anti-tumor effect and tremendous

STING agonist-16 (1a) is a specific stimulator of interferon genes ( STING ) agonist. STING agonist-16 (1a) can be used as a potential antiviral and antitumor tool.In VitroSTING agonist-16 (1a) (0-100 μM, 6 h) can promote mRNA expression of IFNβ,

STING agonist-16 (1a) is a specific stimulator of interferon genes ( STING ) agonist. STING agonist-16 (1a) can be used as a potential antiviral and antitumor tool.In VitroSTING agonist-16 (1a) (0-100 μM, 6 h) can promote mRNA expression of IFNβ,

STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selective and non-nucleotide small-molecule STING agonist with a pEC 50 and pIC 50 of 7.5 and 9.5, respectively. STING agonist-3 has durable anti-tumor effect and tremendous

STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selective and non-nucleotide small-molecule STING agonist with a pEC 50 and pIC 50 of 7.5 and 9.5, respectively. STING agonist-3 has durable anti-tumor effect and tremendous

STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selective and non-nucleotide small-molecule STING agonist with a pEC 50 and pIC 50 of 7.5 and 9.5, respectively. STING agonist-3 has durable anti-tumor effect and tremendous

STING agonist-4 is an stimulator of Interferon Genes (STING) receptor agonist with an apparent inhibitory constant ( IC 50 ) of 20 nM. STING agonist-4 is a two symmetry-related amidobenzimidazole ( ABZI )-based compound to create linked ABZIs

STING agonist-4 is an stimulator of Interferon Genes (STING) receptor agonist with an apparent inhibitory constant ( IC 50 ) of 20 nM. STING agonist-4 is a two symmetry-related amidobenzimidazole ( ABZI )-based compound to create linked ABZIs